| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A BASELINE GENE EXPRESSION-BASED PROGNOSTIC FOR ANTI-TNFα THERAPY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Sakaram, Suraj
|
|
|
160 |
3S |
p. S11
|
artikel
|
| 2 |
ACTIVATED INTESTINAL MUSCLE CELLS PROMOTE PREADIPOCYTE MIGRATION: A NOVEL MECHANISM OF CREEPING FAT FORMATION IN CROHN’S DISEASE
|
Mao, Ren
|
|
|
160 |
3S |
p. S45-S46
|
artikel
|
| 3 |
ADENOSINE A3 RECEPTOR INTERACTS WITH GASDERMIN D TO MODULATE INTESTINAL EPITHELIAL CELL PYROPTOSIS IN ULCERATIVE COLITIS
|
Xiao, Peng
|
|
|
160 |
3S |
p. S31
|
artikel
|
| 4 |
ADHESIONS ARE NOT ALWAYS THE ENEMY: POUCH VOLVULUS
|
Dionigi, Beatrice
|
|
|
160 |
3S |
p. S57-S58
|
artikel
|
| 5 |
“ADULTING” WITH IBD: A NOVEL, VIRTUAL INFLAMMATORY BOWEL DISEASE TRANSITION PROGRAM FOR TEENS AND CAREGIVERS
|
Stellway, Jacklyn
|
|
|
160 |
3S |
p. S71
|
artikel
|
| 6 |
ADVANCING HIGH TECH DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF CROHN’S DISEASE
|
Miller, Douglas
|
|
|
160 |
3S |
p. S2-S3
|
artikel
|
| 7 |
ALBUMIN-BASED NANOPARTICLES FOR DRUG COMBINATION IN INFLAMMATORY BOWEL DISEASE
|
Zhang, Sufeng
|
|
|
160 |
3S |
p. S46
|
artikel
|
| 8 |
AMERICAN GASTROENTEROLOGICAL ASSOCIATION’S QUALITY LEADERSHIP COUNCIL’S PRACTICE WORK GROUP: A NATIONWIDE INITIATIVE TO REDUCE THE USE OF PRESCRIPTION OPIOID AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A LOCAL LEVEL
|
Siva, Shivi
|
|
|
160 |
3S |
p. S65-S66
|
artikel
|
| 9 |
ANALYSIS OF ONLINE INFORMATION ON SUPPORT GROUP MEETINGS FOR CROHN’S DISEASE PATIENTS
|
Moon, Jooyoung
|
|
|
160 |
3S |
p. S71-S72
|
artikel
|
| 10 |
AN AUTOPHAGY PROTEIN ATG16L1 PREVENTS NECROPTOSIS BY REGULATING INTERFERON SIGNALING IN THE INTESTINAL EPITHELIUM
|
Matsuzawa, Yu
|
|
|
160 |
3S |
p. S31-S32
|
artikel
|
| 11 |
A NEW BACTERIAL TRANSFER THERAPY FOR IBD: ENDOSCOPIC BIFIDOBACTERIUM AND XYLOGLUCAN ADMINISTRATION
|
Bozkurt, Hüseyin
|
|
|
160 |
3S |
p. S50-S51
|
artikel
|
| 12 |
A NOVEL APPROACH TO THE ENDOSCOPIC REPAIR OF AN ENTEROCUTANEOUS FISTULA IN A PATIENT WITH CROHN’S DISEASE
|
McKay, Cortney
|
|
|
160 |
3S |
p. S65
|
artikel
|
| 13 |
A NOVEL LANGERIN EXPRESSING TYPE 2-CONVENTIONAL DENDRITIC CELL IS SIGNIFICANTLY DECREASED IN CROHN’S DISEASE
|
Doyle, Chloe
|
|
|
160 |
3S |
p. S43-S44
|
artikel
|
| 14 |
ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY)
|
Whaley, Kaitlin
|
|
|
160 |
3S |
p. S75-S76
|
artikel
|
| 15 |
A POPULATION-BASED APPROACH TO DIGITAL OUTREACH, TRIAGE, AND MONITORING OF IBD PATIENTS DURING THE COVID-19 PANDEMIC
|
Atreja, Ashish
|
|
|
160 |
3S |
p. S7-S8
|
artikel
|
| 16 |
A RARE AND UNFORTUNATE CASE OF PARESTHESIAS SECONDARY TO INFLIXIMAB
|
Dasu, Neethi
|
|
|
160 |
3S |
p. S18-S19
|
artikel
|
| 17 |
A TRANSLATIONAL PHASE I STUDY OF TAUROURSODEOXYCHOLIC ACID (TUDCA) TO REDUCE SYMPTOMS AND ER STRESS IN ACTIVE ULCERATIVE COLITIS
|
Huang, Katherine
|
|
|
160 |
3S |
p. S8
|
artikel
|
| 18 |
A WHOLE FOOD, ANTI-INFLAMMATORY DIET ESTABLISHES A BENEFICIAL GUT MICROBIOME IN INFLAMMATORY BOWEL DISEASE PATIENTS
|
Olednzki, Barbara
|
|
|
160 |
3S |
p. S51
|
artikel
|
| 19 |
BIOLOGICS BEFORE SURGERY FOR IBD: ARE THEY ASSOCIATED WITH POST-OPERATIVE INFECTIOUS COMPLICATIONS? RESULTS FROM THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM INFLAMMATORY BOWEL DISEASE COLLABORATIVE IN >1500 PATIENTS
|
Holubar, Stefan
|
|
|
160 |
3S |
p. S78-S79
|
artikel
|
| 20 |
BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS TREATED WITH BIOLOGICS: A NEW PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
|
Grova, Mauro
|
|
|
160 |
3S |
p. S79
|
artikel
|
| 21 |
BMC322- A RATIONALLY-DESIGNED LIVE BACTERIAL CONSORTIUM BASED ON MICROBIOME FUNCTIONAL GENOMIC ANALYSIS FOR TREATMENT OF IBD
|
Polonsky, Omri
|
|
|
160 |
3S |
p. S51-S52
|
artikel
|
| 22 |
CADHERIN-11, AN ESSENTIAL REGULATOR OF CELL-CELL ADHESION UPREGULATED IN IBD PATIENTS, PLAYS ESSENTIAL ROLES IN PROMOTING FIBROBLAST ACTIVATION AND DEVELOPMENT OF INTESTINAL INFLAMMATION AND FIBROSIS
|
Li, Jiannan
|
|
|
160 |
3S |
p. S46-S47
|
artikel
|
| 23 |
CHARACTERIZATION OF IMMUNE PHENOTYPES AS PREDICTIVE BIOMARKERS FOR RESPONSE TO THE α4β7 INTEGRIN BLOCKER, VEDOLIZUMAB
|
Martinez, Catherine
|
|
|
160 |
3S |
p. S76
|
artikel
|
| 24 |
CIGARETTE SMOKE INCREASES RISK FOR COLORECTAL NEOPLASIA IN INFLAMMATORY BOWEL DISEASE
|
Van Der Sloot, Kimberley
|
|
|
160 |
3S |
p. S19
|
artikel
|
| 25 |
CLINICAL SIGNIFICANCE OF PSOAS MUSCLE COMPOSITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Lin, Bixuan
|
|
|
160 |
3S |
p. S11-S12
|
artikel
|
| 26 |
CLONAL EPIGENETIC MOSAICISM: MECHANISM FOR CROHN’S DISEASE HETEROGENEITY
|
Gupta, Saumya
|
|
|
160 |
3S |
p. S38
|
artikel
|
| 27 |
COLLABORATIVE DEVELOPMENT OF CROHN’S DISEASE CLINICAL DATA STANDARDS BY STANDARDS DEVELOPMENT AND CROHN’S DISEASE EXPERTS TO FOSTER DATA REVIEW, SHARING, AND REUSE
|
Owen, John
|
|
|
160 |
3S |
p. S16-S17
|
artikel
|
| 28 |
COLON SPECIFIC ROLE FOR SELENOPROTEIN P IN COLITIS AND COLITIS-ASSOCIATED CARCINOMA
|
Short, Sarah
|
|
|
160 |
3S |
p. S32-S33
|
artikel
|
| 29 |
COLORECTAL ADENOCARCINOMA DEVELOPING IN A YOUNG FEMALE WITH OVERLAP SYNDROME AND VERY EARLY ONSET-INFLAMMATORY BOWEL DISEASE: A CASE REPORT
|
Kandavel, Prashanthi
|
|
|
160 |
3S |
p. S20
|
artikel
|
| 30 |
COMMON FOOD ADDITIVES ACCELERATE ONSET OF INFLAMMATORY BOWEL DISEASE IN MICE BY ALTERING MICROBIOME COMPOSITION AND HOST-MICROBE INTERACTION
|
Zangara, Megan
|
|
|
160 |
3S |
p. S53
|
artikel
|
| 31 |
COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TUMOR NECROSIS FACTOR AGENTS IN OLDER ADULTS WITH INFLAMMATORY BOWEL DISEASES IN MEDICARE ADMINISTRATIVE CLAIMS DATABASE
|
Kochar, Bharati
|
|
|
160 |
3S |
p. S6-S7
|
artikel
|
| 32 |
Cover
|
|
|
|
160 |
3S |
p. i
|
artikel
|
| 33 |
CRYPTOGENIC MULTIFOCAL ULCEROUS STENOSING ENTERITIS (CMUSE): A 20-YEAR SINGLE CENTER CLINICAL AND RADIOLOGIC EXPERIENCE
|
Piovezani Ramos, Guilherme
|
|
|
160 |
3S |
p. S12-S13
|
artikel
|
| 34 |
DETERMINANTS OF INFLAMMATORY BOWEL DISEASE PATIENT SATISFACTION AFTER TRANSITION TO VIRTUAL VISITS
|
Ghafari-Saravi, Afsoon
|
|
|
160 |
3S |
p. S66
|
artikel
|
| 35 |
DEVELOPMENT OF A PERSONALIZED MODEL OF INTESTINAL FIBROSIS USING HUMAN INTESTINAL ORGANOIDS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS
|
Estrada, Hannah
|
|
|
160 |
3S |
p. S47-S48
|
artikel
|
| 36 |
DEVELOPMENT OF SMALL MOLECULE EPIGENETIC THERAPEUTICS FOR INFLAMMATORY BOWEL DISEASE
|
Li, Yi
|
|
|
160 |
3S |
p. S48
|
artikel
|
| 37 |
DIAGNOSIS CHANGES IN PEDIATRIC IBD: DATA FROM THE IMPROVECARENOW REGISTRY
|
Sandberg, Kelly
|
|
|
160 |
3S |
p. S58
|
artikel
|
| 38 |
DIETARY FIBER DEPRIVATION QUELLS COLONIC INFLAMMATION BY TARGETING GUT PATHOBIONTS IN A NEW MODEL OF CROHN’S DISEASE
|
Caruso, Roberta
|
|
|
160 |
3S |
p. S53-S54
|
artikel
|
| 39 |
DIETARY FIBER GUAR GUM EXACERBATES COLONIC INFLAMMATION IN MULTIPLE EXPERIMENTAL MODELS OF INFLAMMATORY BOWEL DISEASE
|
Nair, Divek V.T.
|
|
|
160 |
3S |
p. S3
|
artikel
|
| 40 |
DIETARY INFLAMMATORY POTENTIAL AND FOOD PATTERNS IN RELATION TO GUT MICROBIOME AMONG CHILDREN WITH CROHN’S DISEASE: A COMPARATIVE STUDY WITH HEALTHY CONTROLS
|
Breton, Jessica
|
|
|
160 |
3S |
p. S54
|
artikel
|
| 41 |
DIFFERENTIALLY EXPRESSED GENE SIGNATURES OF ULCERATIVE COLITIS DETERMINE NOVEL REGULATORS AND PREDICT RESPONSE TO BIOLOGIC THERAPY
|
Penrose, Harrison
|
|
|
160 |
3S |
p. S38-S39
|
artikel
|
| 42 |
DIFFERENTIAL MANIFESTATIONS OF INLAMMATORY BOWEL DISEASE (IBD) BASED ON RAGE AND IMMIGRATION STATUS
|
Crowe, Brooks
|
|
|
160 |
3S |
p. S23-S24
|
artikel
|
| 43 |
DISEASE ACTIVITY, STERIOD-FREE REMISSION, AND CLINICAL OUTCOME ASSESSMENTS OF PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY
|
Hunter, Theresa
|
|
|
160 |
3S |
p. S17
|
artikel
|
| 44 |
DUSP16 IS A NOVEL IBD GENE IMPLICATED IN THE REGULATION OF DIFFERENTIATION AND HOMEOSTASIS OF INTESTINAL EPITHELIAL CELLS
|
Ntunzwenimana, Jessy
|
|
|
160 |
3S |
p. S39
|
artikel
|
| 45 |
DYSREGULATION OF GASTROINTESTINAL RAGE (RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS) EXPRESSION IN A SPONTANEOUS ANIMAL MODEL OF INFLAMMATORY BOWEL DISEASE
|
Cabrera-García, Angela Isabel
|
|
|
160 |
3S |
p. S3-S4
|
artikel
|
| 46 |
EFFECTIVENESS OF ANTIBIOTICS AS A TREATMENT OPTION FOR PATIENTS WITH CROHN’S DISEASE: A META ANALYSIS
|
Patterson, Joshua
|
|
|
160 |
3S |
p. S9
|
artikel
|
| 47 |
EFFECT OF OZANIMOD ON FECAL CALPROTECTIN AND FECAL LACTOFERRIN, BIOMARKERS OF INTESTINAL INFLAMMATION, IN THE PHASE 2 TOUCHSTONE STUDY OF PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS
|
Sandborn, William
|
|
|
160 |
3S |
p. S8-S9
|
artikel
|
| 48 |
EFFICACY OF INFLIXIMAB DOSE ESCALATION IN PATIENTS WITH REFRACTORY IMMUNOTHERAPY-RELATED COLITIS: A CASE SERIES
|
Harris, Jessica
|
|
|
160 |
3S |
p. S79-S80
|
artikel
|
| 49 |
ELEVATED ADENOMATOUS POLYPOSIS COLI IN GOBLET CELLS IS ASSOCIATED WITH INFLAMMATION IN MOUSE AND HUMAN COLON
|
Gomez, Christian
|
|
|
160 |
3S |
p. S33
|
artikel
|
| 50 |
EVALUATING THE ROLE OF GOBLET CELL ASSOCIATED ANTIGEN PASSAGES (GAPS) IN THE DEVELOPMENT OF MUCOSAL IMMUNE TOLERANCE IN THE CFTR KO INTESTINE
|
Young, Sarah
|
|
|
160 |
3S |
p. S44
|
artikel
|
| 51 |
EVALUATION OF A DIET AND ANTIBIOTICS TARGETING THE MICROBIOTA FOR TREATMENT OF MILD TO MODETARE ACTIVE PEDIARTIC ULCERATIVE COLITIS: AN OPEN LABEL PILOT STUDY
|
Sarbagili-Shabat, Chen
|
|
|
160 |
3S |
p. S52
|
artikel
|
| 52 |
EXCESSIVE WEIGHT GAIN IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ON ANTI-TNF THERAPY
|
Mitchel, Elana
|
|
|
160 |
3S |
p. S24-S25
|
artikel
|
| 53 |
EXPLORING CO-INFECTIONS IN THE GASTROINTESTINAL TRACT: DISSECTING THE INTERACTION BETWEEN FUSOBACTERIUM NUCLEATUM AND CLOSTRIDIODES DIFFICILE
|
Engevik, Melinda
|
|
|
160 |
3S |
p. S54-S55
|
artikel
|
| 54 |
EXPLORING THE REPRODUCTIVE HEALTH DECISION EXPERIENCES AND PREFERENCES OF WOMEN WITH INFLAMMATORY BOWEL DISEASES
|
Picciarelli, Zach
|
|
|
160 |
3S |
p. S66-S67
|
artikel
|
| 55 |
FECAL METABOLOMIC ANALYSIS OF SERT DEFICIENT MICE UNDER BASAL CONDITIONS AND CHRONIC COLITIS
|
Sharma, Anchal
|
|
|
160 |
3S |
p. S52-S53
|
artikel
|
| 56 |
FK506 BINDING PROTEIN 8 (FKBP8) INTERACTIONS WITH MYOSIN LIGHT CHAIN KINASE 1 ARE REQUIRED FOR TNF-INDUCED TIGHT JUNCTION BARRIER LOSS
|
Zuo, Li
|
|
|
160 |
3S |
p. S33
|
artikel
|
| 57 |
GENETIC POLYMOPRHISMS MAY DIFFERENTIATE BETWEEN COMPLICATED PEDIATRIC SMALL BOWEL VERSUS COLONIC CROHN’S DISEASE
|
Patel, Halee
|
|
|
160 |
3S |
p. S39-S40
|
artikel
|
| 58 |
GENETIC SUSCEPTIBILITY TO IBD OPERATES VIA CONTROL OF APICAL JUNCTIONAL COMPLEXES
|
Hébert-Milette, Isabelle
|
|
|
160 |
3S |
p. S40
|
artikel
|
| 59 |
GPR120 MAINTAINS INTESTINAL HOMEOSTASIS THROUGH REGULATION OF CD4+ T CELL IL-10 PRODUCTION
|
Yang, Wenjing
|
|
|
160 |
3S |
p. S44
|
artikel
|
| 60 |
GUT-DIRECTED SELF-HYPNOSIS FOR INFLAMMATORY BOWEL DISEASE PROTOCOL: COMPLIMENTARY PSYCHOTHERAPY FOR REMISSION AUGMENTATION, IBS-LIKE SYMPTOMS, AND SURGERY RECOVERY
|
Paulton, Joshua
|
|
|
160 |
3S |
p. S72
|
artikel
|
| 61 |
HEPATITIS VACCINATION AND ANTIBODY STATUS AMONG U.S. ADULTS WITH INFLAMMATORY BOWEL DISEASE
|
Moon, Jooyoung
|
|
|
160 |
3S |
p. S67
|
artikel
|
| 62 |
IDENTIFICATION OF SELETIVE CLAUDIN CATION CHANNEL BLOCKERS
|
Ma, Jingjing
|
|
|
160 |
3S |
p. S33-S34
|
artikel
|
| 63 |
IDENTIFYING INADEQUATE RESPONSE AMONG CROHN’S DISEASE PATIENTS ON A BIOLOGIC IN A REAL-WORLD ADMINISTRATIVE CLAIMS DATABASE
|
Hunter, Theresa
|
|
|
160 |
3S |
p. S25-S26
|
artikel
|
| 64 |
IDENTIFYING INADEQUATE RESPONSE AMONG ULCERATIVE COLITIS PATIENTS ON AN ADVANCED THERAPY IN A REAL-WORLD ADMINISTRATIVE CLAIMS DATABASE
|
Naegeli, April
|
|
|
160 |
3S |
p. S26-S27
|
artikel
|
| 65 |
IDENTIFYING RELEVANT PATHWAYS AND BIOMARKERS IN CROHN’S DISEASE USING CONTEXTUALIZED METABOLIC NETWORK MODEL
|
McGrew, Brooklyn
|
|
|
160 |
3S |
p. S13
|
artikel
|
| 66 |
IMMATURE LOW-DENSITY NEUTROPHILS AS MEDIATORS OF PYODERMA GANGRENOSUM AND INFLAMMATORY BOWEL DISEASE PATHOGENESIS
|
Jatana, Samreen
|
|
|
160 |
3S |
p. S20
|
artikel
|
| 67 |
IMPACT OF DIET ON INFLAMMATORY BOWEL DISEASE SYMPTOMS: AN ADOLESCENT VIEWPOINT
|
Zangara, Megan
|
|
|
160 |
3S |
p. S80
|
artikel
|
| 68 |
IMPACT OF TIME-TO-TEST FOR CLOSTRIDIOIDES DIFFICILE INFECTION ON LENGTH OF STAY IN INFLAMMATORY BOWEL DISEASE PATIENTS HOSPITALIZED WITH FLARE
|
Verma, Abhishek
|
|
|
160 |
3S |
p. S67-S68
|
artikel
|
| 69 |
IMPROVING PATIENT PARTICIPATION IN LONGITUDINAL RESEARCH: AN INNOVATIVE PATIENT-LED PATIENT-ORIENTED QUALITATIVE RESEARCH PROJECT TO UNDERSTAND THE MOTIVATIONS AND BARRIERS TO GETTING AND STAYING INVOLVED IN THE IMAGINE SPOR STUDY
|
Zelinsky, Sandra
|
|
|
160 |
3S |
p. S68-S69
|
artikel
|
| 70 |
INCIDENCE AND RISK FACTORS FOR NEOPLASIA IN INFLAMMATORY BOWEL DISEASE
|
Lemos Garcia, Joana
|
|
|
160 |
3S |
p. S58-S59
|
artikel
|
| 71 |
INCREASED CATHEPSIN EXPRESSION CORRELATES WITH SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS
|
Alvarado, David
|
|
|
160 |
3S |
p. S34
|
artikel
|
| 72 |
INFLAMMATORY BOWEL DISEASE CLASSIFICATION USING THE GUT MICROBIOME: A BENCHMARK OF MICROBIAL DATA ANALYSIS METHODS
|
Kubinski, Ryszard
|
|
|
160 |
3S |
p. S55
|
artikel
|
| 73 |
INFLAMMATORY CYTOKINES AND MICROBIAL LIGANDS AND METABOLITES INTERACT TO MODULATE DUOX2 EXPRESSION AND ACTIVITY
|
Hazime, Hajar
|
|
|
160 |
3S |
p. S35
|
artikel
|
| 74 |
INHIBITION OF DAPK3, PINPOINTED AS A KEY FACTOR IN THE DEVELOPMENT OF COLITIS-ASSOCIATED DYSPLASIA, INCREASES SEVERITY OF DSS-INDUCED COLITIS VIA HIPPO SIGNALING
|
Chen, Tina Huey-Miin
|
|
|
160 |
3S |
p. S48-S49
|
artikel
|
| 75 |
IS ILEOANAL POUCH EXCISION A DESTINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE? DATA FROM A QUATERNARY POUCH REFERRAL CENTER
|
Choi, Sarah
|
|
|
160 |
3S |
p. S20-S21
|
artikel
|
| 76 |
KAPOSI SARCOMA IN AN IMMUNOSUPPRESSED PATIENT WITH PRESUMED CROHN’S DISEASE: IATROGENIC OR EPIDEMIC?
|
Claytor, Jennifer
|
|
|
160 |
3S |
p. S1
|
artikel
|
| 77 |
LOSS OF GLUTATHIONE PEROXIDASE 1 ATTENUATES COLITIS AND IS CRITICAL IN ACTIVATING EPITHELIAL REGENERATIVE RESPONSES
|
Hendren, Jared
|
|
|
160 |
3S |
p. S35
|
artikel
|
| 78 |
LOW DOSE IL-2 FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS
|
Allegretti, Jessica
|
|
|
160 |
3S |
p. S9-S10
|
artikel
|
| 79 |
MACHINE LEARNING FOR CROHN’S DISEASE PHENOTYPE MODELING USING BIOPSY IMAGES
|
Syed, Sana
|
|
|
160 |
3S |
p. S14
|
artikel
|
| 80 |
MESENCHYMAL TNFR1 EXPRESSION PRESERVES THE COLONIC EPITHELIAL STEM CELL NICHE
|
Gadeock, Safina
|
|
|
160 |
3S |
p. S10-S11
|
artikel
|
| 81 |
METHYLTRANSFERASE SMYD5 EXAGGERATES INFLAMMATORY BOWEL DISEASE BY REGULATING PPAR-γ COACTIVATOR 1-α STABILITY
|
Hou, Yuning
|
|
|
160 |
3S |
p. S35-S36
|
artikel
|
| 82 |
MICROBIAL SHIFTS ARE ASSOCIATED WITH PATIENT-REPORTED SYMPTOMS IRRESPECTIVE OF MUCOSAL INFLAMMATION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Hellmann, Jennifer
|
|
|
160 |
3S |
p. S55-S56
|
artikel
|
| 83 |
MINIMAL INVASIVE MANAGEMENT OF PEDIATRIC CROHN’S ANORECTAL STRICTURE, LESS IS MORE
|
Rocourt, Dorothy
|
|
|
160 |
3S |
p. S21-S22
|
artikel
|
| 84 |
MODERATE TO SEVERE ENDOSCOPIC INFLAMMATION IS FREQUENT AFTER ACHIEVING CLINICAL REMISSION IN PEDIATRIC ULCERATIVE COLITIS
|
Sarbagili-Shabat, Chen
|
|
|
160 |
3S |
p. S17-S18
|
artikel
|
| 85 |
MUC1-C IS A DRUGGABLE TARGET FOR TREATMENT OF COLITIS AND PROGRESSION OF COLITIS-ASSOCIATED COLORECTAL CANCER
|
Morimoto, Yoshihiro
|
|
|
160 |
3S |
p. S4-S5
|
artikel
|
| 86 |
NANOPARTICLE-ENCAPSULATED BROMODOMAIN-CONTAINING PROTEIN 4 INHIBITORS FOR THERAPEUTICS OF INFLAMMATORY BOWEL DISEASE
|
Shah, Mansi
|
|
|
160 |
3S |
p. S5
|
artikel
|
| 87 |
NATIONWIDE ANALYSIS OF THE IMPACT OF NAFLD ON CLINICAL OUTCOMES IN IBD PATIENTS
|
Noorian, Shaya
|
|
|
160 |
3S |
p. S59-S60
|
artikel
|
| 88 |
NEUTROPHILS ALTER DSB REPAIR PATHWAY IN INFLAMED MUCOSA TO PROMOTE COLON CARCINOGENESIS
|
Bui, Triet
|
|
|
160 |
3S |
p. S44-S45
|
artikel
|
| 89 |
NOVEL GENETIC SUSCEPTIBILITY CANDIDATES IN GRANULOMATOUS AND NON-GRANULOMATOUS PEDIATRIC CROHN’S DISEASE
|
Hodgkins, Allyson
|
|
|
160 |
3S |
p. S40
|
artikel
|
| 90 |
OBSTRUCTED LYMPHATIC TRANSPORT AND LEAKAGE DRIVEN BY MESENTERIC TERTIARY LYMPHOID ORGANS IS A FEATURE OF CROHN’S DISEASE MOUSE MODEL
|
Czepielewski, Rafael
|
|
|
160 |
3S |
p. S45
|
artikel
|
| 91 |
OUTCOMES FOR PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND IBD: ULCERATIVE COLITIS VERSUS CROHN’S DISEASE- AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2015–2017
|
Dasu, Neethi
|
|
|
160 |
3S |
p. S27
|
artikel
|
| 92 |
PAIN MEDICATION USE AMONG CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS BEFORE AND AFTER INITIATION OF BIOLOGIC THERAPY
|
Hunter, Theresa
|
|
|
160 |
3S |
p. S27-S28
|
artikel
|
| 93 |
PATIENTS’ JOURNEY THROUGH INFLAMMATORY BOWEL DISEASE (IBD): A QUALITATIVE STUDY
|
Omprakash, Tina Aswani
|
|
|
160 |
3S |
p. S72-S73
|
artikel
|
| 94 |
PATIENTS WITH INFLAMMATORY BOWEL DISEASE PERSPECTIVE ON COVID-19 AND HEALTH CARE SERVICE DURING THE PANDEMIC
|
Opheim, Randi
|
|
|
160 |
3S |
p. S69
|
artikel
|
| 95 |
PERFORMANCE CHARACTERISTICS OF A FRET-BASED IMMUNOASSAY FOR QUANTITATION OF ADALIMUMAB ON A POINT-OF-CARE INSTRUMENT SYSTEM
|
Ong, Edgar
|
|
|
160 |
3S |
p. S76-S77
|
artikel
|
| 96 |
PERFORMANCE CHARACTERISTICS OF A FRET-BASED IMMUNOASSAY FOR QUANTITATION OF INFLIXIMAB ON A POINT-OF-CARE INSTRUMENT SYSTEM
|
Ong, Edgar
|
|
|
160 |
3S |
p. S77
|
artikel
|
| 97 |
PHENOTYPIC ALTERATIONS OF MACROPHAGE CONTRIBUTES TO EXTRACELLULAR MATRIX DEPOSITION IN CULTURED MACROPHAGE RAW 264.7
|
Li, Chao
|
|
|
160 |
3S |
p. S49
|
artikel
|
| 98 |
PHOTOVOICE AS A TOOL TO IMPROVE PATIENT - PROVIDER COMMUNICAITON IN INFLAMMATORY BOWEL DISEASE CLNIIC: A PILOT OF FEASIBILITY STUDY
|
Gorbenko, Ksenia
|
|
|
160 |
3S |
p. S73-S74
|
artikel
|
| 99 |
POLYSUBSTANCE USE IN INFLAMMATORY BOWEL DISEASE
|
Bogale, Kaleb
|
|
|
160 |
3S |
p. S74
|
artikel
|
| 100 |
PRO-INFLAMMATORY MOLECULAR AND INFLAMMATORY MECHANISMS OF SULFUR METABOLISM IN IBD-RELEVANT CLOSTRIDIA SPECIES
|
Suarez, Gabriel
|
|
|
160 |
3S |
p. S41
|
artikel
|
| 101 |
PROTON PUMP INHIBITORS (PPI) INDUCES COLONIC TIGHT JUNCTION BARRIER (TJ) DYSFUNCTION VIA AN UPREGULATION OF TJ PORE FORMING CALUDIN-2 PROTEIN
|
Nighot, Meghali
|
|
|
160 |
3S |
p. S36
|
artikel
|
| 102 |
RECENT APPROACHES FOR SMOKING CESSATION IN CROHN’S DISEASE: A QUALITATIVE REVIEW
|
Moon, Jooyoung
|
|
|
160 |
3S |
p. S69-S70
|
artikel
|
| 103 |
REGULATION OF HUMAN INTESTINAL ORGANOID REACTIVE OXYGEN SPECIES PRODUCTION AND MITOCHONDRIAL FUNCTION BY DUOX2 GENETIC VARIATION AND MICROBIAL PRODUCTS
|
Jurickova, Ingrid
|
|
|
160 |
3S |
p. S41-S42
|
artikel
|
| 104 |
REINVENTING INFLAMMATORY BOWEL DISEASE (IBD) CLINICAL TRIAL RECRUITMENT USING NOVEL DIGITAL MEDICINE TOOLS
|
Fasihuddin, Farah
|
|
|
160 |
3S |
p. S10
|
artikel
|
| 105 |
RESULTS FROM A NATIONAL CROSS-SECTIONAL STUDY OF DISEASE BURDEN IN CROHN’S DISEASE
|
Seabury, Jamison
|
|
|
160 |
3S |
p. S18
|
artikel
|
| 106 |
RISK FACTORS FOR OUTCOMES OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS
|
Voth, Elida
|
|
|
160 |
3S |
p. S49-S50
|
artikel
|
| 107 |
RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY
|
Faye, Adam
|
|
|
160 |
3S |
p. S60
|
artikel
|
| 108 |
RISK OF ANAL CANCER IN INFLAMMATORY BOWEL DISEASE PATIENTS IN THE US: A POPULATION-BASED STUDY 2008–2018
|
Suk, Ryan
|
|
|
160 |
3S |
p. S28-S29
|
artikel
|
| 109 |
ROLE OF CHEMERIN IN THE PATIENTS WITH INFLAMMATORY BOWEL DISEASES
|
Sochal, Marcin
|
|
|
160 |
3S |
p. S18
|
artikel
|
| 110 |
ROLE OF MAGNETIC RESONANCE ENTEROGRAPHY IN THE DIAGNOSTICS OF ACTIVE CROHN’S DISEASE IN CHILDREN
|
Siejka, Karolina
|
|
|
160 |
3S |
p. S15
|
artikel
|
| 111 |
SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
|
Hanauer, Stephen
|
|
|
160 |
3S |
p. S1-S2
|
artikel
|
| 112 |
SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
|
Ruan, Wenly
|
|
|
160 |
3S |
p. S60-S61
|
artikel
|
| 113 |
SELF-COMPASSION IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE: RELATIONSHIP OF SELF-COMPASSION TO PSYCHOLOGICAL AND PHYSICAL OUTCOMES
|
Neiman, Nicole
|
|
|
160 |
3S |
p. S74-S75
|
artikel
|
| 114 |
SER-287, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC FOR PATIENTS WITH ACTIVE MILD-TO-MODERATE ULCERATIVE COLITIS, PRODUCES REMISSION ASSOCIATED METABOLITES, REDUCES INTESTINAL EPITHELIAL IL-8 SECRETION AND PROTECTS EPITHELIAL BARRIER FUNCTION IN VITRO
|
Martínez, Asunción
|
|
|
160 |
3S |
p. S56-S57
|
artikel
|
| 115 |
SHAPE MEMORY POLYMER HYDROGEL FOAMS FOR FISTULA CLOSURE
|
Monroe, Mary
|
|
|
160 |
3S |
p. S22
|
artikel
|
| 116 |
SMALL-BOWEL CAPSULE ENDOSCOPY IN INFLAMMATORY BOWEL DISEASE TYPE UNCLASSIFIED
|
Singeap, Ana-Maria
|
|
|
160 |
3S |
p. S15
|
artikel
|
| 117 |
SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501
|
Macaluso, Fabio Salvatore
|
|
|
160 |
3S |
p. S80
|
artikel
|
| 118 |
SPROUTY2 INHIBITS EXPRESSION OF THE HOST DEFENSE PEPTIDE RELMβ IN THE COLONIC EPITHELIUM
|
Schumacher, Michael
|
|
|
160 |
3S |
p. S36-S37
|
artikel
|
| 119 |
STOCHASTIC INTERINDIVIDUAL MICROBIOME VARIATION MAY GUIDE PROTECTIVE PERINATAL PROBIOTIC DEVELOPMENT AGAINST IBD
|
Krishna, Mahesh
|
|
|
160 |
3S |
p. S5
|
artikel
|
| 120 |
TARGETING SIDEROPHORES TO REDUCE COLONIZATION OF ADHERENT INVASIVE E. COLI IN CROHN’S DISEASE
|
Gerner, Romana
|
|
|
160 |
3S |
p. S45
|
artikel
|
| 121 |
TELEMEDICINE IN IBD: GOOD TRUST FROM OUTPATIENTS DURING THE COVID-19 PANDEMIC IN MILAN (LOMBARDY)
|
Costantino, Andrea
|
|
|
160 |
3S |
p. S70
|
artikel
|
| 122 |
THE CLINICAL FEATURES AND PROGNOSTIC VALUE OF INFLAMMATORY POLYPS IN THE J POUCH OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED BY PROCTOCOLECTOMY WITH ILEAL POUCH-ANAL ANASTOMOSIS
|
Akiyama, Shintaro
|
|
|
160 |
3S |
p. S61-S62
|
artikel
|
| 123 |
THE CUMULATIVE INCIDENCE OF POUCHITIS AND POUCH-RELATED COMPLICATIONS IN PEDIATRIC PATIENTS WITH ULCERATIVE COLITIS
|
Cowherd, Ellen
|
|
|
160 |
3S |
p. S2
|
artikel
|
| 124 |
THE EVALUATION OF SERUM SEROTONIN LEVEL AMONG PATIENTS WITH CROHN’S DISEASE AND ITS IMPACT ON QUALITY OF LIFE
|
Sochal, Marcin
|
|
|
160 |
3S |
p. S75
|
artikel
|
| 125 |
THE IMPACT OF INTERMEDIATE TITER ANTIBODIES TO ADALIMUMAB (ATA) AND INFLIXIMAB (ATI) ON CLINICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE (CD) OR ULCERATIVE COLITIS (UC)
|
Wang, Chaoyang
|
|
|
160 |
3S |
p. S77-S78
|
artikel
|
| 126 |
THE IMPLEMENTATION OF A PILOT STUDY OF A STANDARDIZED INFLAMMATORY BOWEL DISEASE CURRICULUM FOR GASTROENTEROLOGY FELLOWS
|
Mulgund, Aditi
|
|
|
160 |
3S |
p. S70-S71
|
artikel
|
| 127 |
THE MUCOSAL MICRORNA PROFILE RELATES TO AGE AND SEVERITY OF DISEASE IN PATIENTS WITH ULCERATIVE COLITIS
|
Malham, Mikkel
|
|
|
160 |
3S |
p. S15
|
artikel
|
| 128 |
THE ROLE OF MYELOPEROXIDASE AND NEUTROPHIL EXTRACELLULAR TRAPS IN THE PATHOGENESIS OF INFLAMMATORY BOWEL DISEASE
|
Chami, Belal
|
|
|
160 |
3S |
p. S5-S6
|
artikel
|
| 129 |
THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSIS
|
Li, Muyi
|
|
|
160 |
3S |
p. S62
|
artikel
|
| 130 |
THE TIGHT JUNCTION PROTEIN ZO-1 REGULATES MITOTIC SPINDLE ORIENTATION TO ENABLE EFFICIENT MUCOSAL REPAIR
|
Kuo, Wei-Ting
|
|
|
160 |
3S |
p. S37
|
artikel
|
| 131 |
TOXICOLOGICAL FINDINGS OF A RECOMBINANT CHOLERA TOXIN B SUBUNIT VARIANT WITH THERAPEUTIC POTENTIAL IN ULCERATIVE COLITIS
|
Reeves, Micaela
|
|
|
160 |
3S |
p. S6
|
artikel
|
| 132 |
TRANSFER RNA QUEUOSINE MODIFICATION ENZYME MANIPULATES TIGHT JUNCTION PROTEINS IN INFLAMMATORY BOWEL DISEASE
|
Zhang, Jilei
|
|
|
160 |
3S |
p. S37
|
artikel
|
| 133 |
TREATMENT PATTERNS OF NEWLY DIAGNOSED PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS IN THE IMPROVECARENOW REGISTRY
|
Hunter, Theresa
|
|
|
160 |
3S |
p. S29-S30
|
artikel
|
| 134 |
TWISTED POUCH SYNDROME - A DIFFICULT TO DIAGNOSE MECHANICAL COMPLICATION OF ILEAL POUCH-ANAL ANASTOMOSIS: OUTCOMES AFTER REDO POUCH PROCEDURES
|
Holubar, Stefan
|
|
|
160 |
3S |
p. S22-S23
|
artikel
|
| 135 |
ULTRASOUND - FIRST-LINE IMAGING MODALITY IN EVALUATION OF THE INFLAMMATORY BOWEL LESIONS IN CHILDREN
|
Grzegorczyk, Magdalena
|
|
|
160 |
3S |
p. S15-S16
|
artikel
|
| 136 |
UNDERSTANDING REAL-WORLD BIOLOGIC MAINTENANCE DOSING PATTERNS AMONG PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS
|
Crandall, Wallace
|
|
|
160 |
3S |
p. S30
|
artikel
|
| 137 |
UNIQUE GENE EXPRESSION IN GUT-DERIVED PHAGOCYTIC IMMUNE CELLS FROM IBD PATIENTS
|
Jacobsen, Gillian
|
|
|
160 |
3S |
p. S42-S43
|
artikel
|
| 138 |
URINARY BLADDER NECROSIS - AN EXTRAINTESTINAL MANIFESTATION OF INFLAMMATORY BOWEL DISEASE IN A PEDIATRIC PATIENT
|
Norris, Nicholas
|
|
|
160 |
3S |
p. S23
|
artikel
|
| 139 |
USTEKINUMAB FOR CHRONIC GRANULOMATOUS DISEASE-ASSOCIATED INFLAMMATORY BOWEL DISEASE
|
Bhattacharya, Sumona
|
|
|
160 |
3S |
p. S80-S81
|
artikel
|
| 140 |
UTILIZATION OF WHOLE EXOME SEQUENCING DATA TO IDENTIFY CLINICALLY RELEVANT PHARMACOGENOMIC VARIANTS IN INFLAMMATORY BOWEL DISEASE
|
Mulder, Daniel
|
|
|
160 |
3S |
p. S43
|
artikel
|
| 141 |
VALIDATION OF HPTM-001, A HUMANIZED CANDIDATE THERAPEUTIC ANTIBODY FOR PROMOTING MUCOSAL WOUND HEALING IN IBD
|
Liang, Tony
|
|
|
160 |
3S |
p. S50
|
artikel
|
| 142 |
VISCERAL ADIPOSE TISSUE INFLUENCES ANTI-TUMOR NECROSIS FACTOR (TNF) TREATMENT RESPONSE IN IBD
|
Gu, Phillip
|
|
|
160 |
3S |
p. S63
|
artikel
|
| 143 |
VISCERAL FAT INDEX INFORMS RISK OF MEDICALLY REFRACTORY IBD AND NEED FOR SURGERY IN PATIENTS STARTING ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY
|
Gu, Phillip
|
|
|
160 |
3S |
p. S64
|
artikel
|
| 144 |
WEARABLE SWEAT SENSING DEVICE FOR DETECTION OF IBD BIOMARKERS
|
Jagannath, Badrinath
|
|
|
160 |
3S |
p. S16
|
artikel
|
Tijdschrift beschrijving